High-Frequency Ultrasound Echocardiography to Assess Zebrafish Cardiac Function
March 12th, 2020
8.9K views
We describe a protocol to assess heart morphology and function in adult zebrafish using high-frequency echocardiography. The method allows visualization of the heart and subsequent quantification of functional parameters, such as heart rate (HR), cardiac output (CO), fractional area change (FAC), ejection fraction (EF), and blood inflow and outflow velocities.
Overview
This article describes a noninvasive protocol for assessing heart morphology and function in adult zebrafish using high-frequency echocardiography. The method enables visualization and quantification of various cardiac parameters, facilitating the study of heart disease models and drug screening.
Key Study Components
Area of Science
- Neuroscience
- Cardiology
- Zebrafish Models
Background
- High-frequency echocardiography provides detailed heart imaging.
- The method is suitable for adult zebrafish, a common model organism.
- Noninvasive techniques allow for rapid recovery of subjects.
- Useful for validating heart disease models and screening potential drugs.
Purpose of Study
- To assess heart morphology and function in zebrafish.
- To provide a reliable method for cardiac parameter quantification.
- To facilitate research in cardiac health and disease.
Methods Used
- High-frequency echocardiography for imaging.
- Noninvasive positioning of zebrafish for accurate imaging.
- Quantification of heart rate, cardiac output, and ejection fraction.
- Rapid recovery of fish post-imaging.
Main Results
- Successful visualization of adult zebrafish heart function.
- Accurate measurement of functional parameters.
- Reproducible results across multiple trials.
- Validation of the method for future cardiac research.
Conclusions
- The protocol offers a reliable approach to study zebrafish cardiac function.
- It supports the development of heart disease models.
- Potential applications in drug screening and cardiovascular research.
Frequently Asked Questions
What is high-frequency echocardiography?
It is a noninvasive imaging technique used to visualize heart function in zebrafish.
Why use zebrafish for cardiac studies?
Zebrafish are a valuable model organism due to their transparent embryos and rapid development.
What parameters can be measured using this method?
Heart rate, cardiac output, fractional area change, and ejection fraction can be quantified.
Is the procedure harmful to the zebrafish?
The method is noninvasive and allows for rapid recovery of the fish.
Can this technique be used for drug screening?
Yes, it can be applied to assess the effects of potential drugs on heart function.
How does this method compare to traditional imaging?
It provides higher resolution and is less invasive, allowing for better recovery of the subjects.
Executive Industry Relevance
High-frequency ultrasound echocardiography enables non-invasive cardiac phenotyping in adult zebrafish, addressing a critical gap in modeling age-related heart conditions. This approach supports target validation and mechanistic de-risking by providing quantitative functional readouts such as ejection fraction and stroke volume. The method enhances predictive confidence in preclinical cardiovascular research and drug screening workflows.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through visualization of heart dimension and functional parameters in disease models.
- Operational Value: Supports biological de-risking by quantifying ventricular systolic function and chamber dimensions in adult zebrafish.
- Predictive Value: Facilitates portfolio triage by delivering reproducible cardiac output and heart rate measurements for lead compound evaluation.
Screening & Assay Development
- Scientific Value: Provides validated biological systems for downstream drug screens via non-invasive imaging of ventricular inflow and outflow velocities.
- Operational Value: Ensures assay standardization and reproducibility through consistent transducer positioning and image acquisition protocols.
- Scalability: Enables platform reuse across species (e.g., murine and zebrafish) by adapting transducers on the same imaging system.
Translational & Preclinical Research
- Translational Continuity: Supports disease-relevant system modeling for late-onset cardiac conditions through longitudinal functional monitoring.
- Mechanistic De-risking: Connects discovery through preclinical validation by delivering functional data such as fractional area change and end systolic volume.
- Risk-Adjusted Advancement: Informs decision-making by establishing cardiac phenotype baselines for injury, recovery, and regenerative capacity studies.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from Early Discovery to Lead Identification and Preclinical work by enabling non-invasive, repeatable cardiac function assessment in adult zebrafish.
- Discovery Biology: Supports hypothesis testing and pathway clarification via visualization of heart dimension and quantification of stroke volume and cardiac output.
- Screening: Delivers assay readiness and quantitative outputs through color Doppler and pulse wave Doppler measurements of blood flow velocity.
- Analytics: Generates heart rate, ejection fraction, and ventricular dimensions that enable cross-condition comparison and compound effect tracking.
- Translational Research: Connects to preclinical continuity by validating heart disease models and assessing drug effects on functional recovery.
- Enterprise Reuse: Positions the ultrasound platform as a reusable capability across species and projects via transducer adaptation.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence, target validation, reduction of mechanistic ambiguity in cardiac phenotyping.
- Operational Value: Standardization, reproducibility, and scalability of cardiac function measurements across studies.
- Strategic Value: Better go/no-go decisions, capital efficiency, and reduced late-stage biological risk in cardiovascular programs.
- Portfolio Impact: Risk-adjusted prioritization and advancement decisions based on quantitative functional thresholds.
Implementation Considerations
- Required expertise in ultrasound imaging, zebrafish handling, and cardiac parameter analysis.
- Instrumentation needs include high-frequency ultrasound platform, micromanipulator, and transducer with appropriate frequency range.
- Cross-team standardization requires consistent anesthesia protocols, imaging planes, and measurement tracings.
- Adaptation considerations involve adjusting transducer frequency and gain settings for zebrafish versus murine models.
- Practical limitations include cost of high-frequency ultrasound systems and learning curve for Doppler-based flow quantification.
Biopharma FAQs
Why does heart rate measurement matter for target validation in zebrafish?
Heart rate is a key functional parameter obtained by tracing aortic flow peaks in pulse wave Doppler images, providing a baseline for assessing chronotropic effects of genetic or pharmacological interventions in disease models.
How does isolation of ventricular inflow velocity support the discovery pipeline?
Positioning the sample volume gate at the atrioventricular valve to detect maximum inflow velocity enables quantification of diastolic function, which helps isolate the impact of compounds on filling dynamics independent of contractility.
What do ejection fraction and fractional area change enable in preclinical assessment?
These systolic function parameters, derived from B-mode tracing of ventricular inner wall at systole and diastole, quantify contractile performance and allow comparison of therapeutic efficacy across disease models and treatment groups.
Why are replication requirements important for cross-functional collaboration in cardiac phenotyping?
Reproducible results across multiple trials, enabled by standardized platform setup and image acquisition, ensure that cardiology, toxicology, and drug discovery teams can trust functional data for go/no-go decisions.
What statistical analysis capabilities are required before implementing zebrafish echocardiography in screening?
Teams must be able to analyze ventricular dimensions, stroke volume, and cardiac output distributions to establish baseline variability and detect significant changes in functional parameters with adequate power.
